In vitro research has identified higher Gln in cancer stem cells with CD44(+) expression compared to CD44(−), with Gln additionally related to glutamate and Notch signaling via glutaminase, while CD133(+) appears to be linked to Gly [14]. The gene discussed is PROM1; the disease is cancer.